Summary & Overview
HCPCS J1756: Injection, Iron Sucrose, 1 mg
HCPCS Level II code J1756 denotes an injection of iron sucrose, billed per 1 mg, used for intravenous iron replacement therapy. This code is significant nationally because intravenous iron is commonly administered across outpatient infusion centers, physician offices, and hospital outpatient departments to manage iron deficiency and iron-deficiency anemia when oral therapy is inadequate or not tolerated. Proper coding of J1756 affects drug utilization reporting, clinical documentation, and payer reimbursement for a high-cost, frequently used parenteral medication.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for intravenous iron sucrose, common sites of service, and what to expect in billing practice for a per-milligram drug code. The publication also outlines typical benchmarks and payment considerations, common modifier use (listed separately), and areas where policy updates or payer-specific requirements may influence claims processing. Practical takeaways include how J1756 maps to therapeutic administration, the importance of accurate dosing and documentation, and where to look for payer-specific guidance. Data not available in the input is explicitly noted where applicable.
Billing Code Overview
HCPCS Level II code J1756 represents an injection of iron sucrose, billed per 1 mg of the drug. The service is a parenteral iron replacement therapy intended to treat iron deficiency or iron-deficiency anemia when intravenous iron is indicated. Typical service type is therapeutic injection/infusion. The usual site of service for administration is an outpatient infusion suite, physician office, or hospital outpatient department.
Service line: Data not available in the input.
ICD-10 diagnoses: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 58-year-old female with chronic kidney disease stage 4 presents to the outpatient infusion clinic with symptomatic iron-deficiency anemia (fatigue, dyspnea on exertion) unresponsive to oral iron. The clinician documents laboratory-confirmed iron deficiency (ferritin low, transferrin saturation low) and prescribes intravenous iron sucrose dosed per weight. Vitals and pre-administration checks are completed by an infusion nurse; intravenous access is obtained and the ordered dose of J1756 (iron sucrose, billed per mg) is administered over the recommended infusion time with monitoring for hypersensitivity reactions. Post-infusion observation and documentation of dose administered, lot number, and any adverse events are recorded in the medical record. Billing is submitted by the facility for the actual milligrams administered using J1756 units and any applicable service or location modifiers.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day | Use when a distinct E/M visit is performed the same day as the infusion and is medically necessary and documented |